Rejuveron raises $20 million for Endogena to advance treatment for eye diseases
CISION PR Newswire - 31-Dec-2021Funds to develop regenerative therapies for retinitis pigmentosa and advanced age-related macular degeneration
Join the club for FREE to access the whole archive and other member benefits.
Founder of Apeiron Investment Group and Presight Capital
Christian Angermayer is an entrepreneur, investor and film enthusiast. He is the founder of Apeiron Investment Group and Presight Capital. Apeiron focuses on Financial Services (especially fintech and crypto assets), Technology, Life Sciences, Media & Entertainment and Real Estate. Christian has created, co-founded and invested in numerous successful companies.
In 2000, Christian co-founded Ribopharma (original patents for RNAi technology) which merged with US peer Alnylam in 2003 and subsequently went public. With his biotech company atai Life Sciences, Christian has the ambitious goal to enable people to live healthier and happier lives.
Passionate about the arts and film, Christian has (executive) produced 14 feature films including critically acclaimed movies like Filth, Aspern Papers and Hector and the Search for Happiness.
Visit website: https://christian-angermayer.de/
See also: Apeiron Investment Group - Investment company focused on life sciences, deep technology, and financial services
Details last updated 21-May-2021
10-May-2022
Symposium about healthy living organized by Rejuveron (FREE)
Funds to develop regenerative therapies for retinitis pigmentosa and advanced age-related macular degeneration
Novel business approach helps people to live longer with good health
New competitor for Neuralink's brain implant, streamlining solution for neurological disorders